Drug Class Detail

Drug Class GSK-3beta Inhibitor


  • Case insensitive filtering will display rows where any text in any cell matches the filter term
  • Simple literal full or partial string matches
  • Separate multiple filter terms with a spaces, order doesn't matter (a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page, filtering has no impact on query parameters
  • Use quotes to match a longer phrase which contains spaces "mtor c1483f"


  • Generally, the default sort order for tables is set to be first column ascending, however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column, be sure to set ascending or descending order for a given column, before moving on to the next column.

Drug Name Trade Name Synonyms Drug Classes Drug Description
PHA-533533 CDK1 Inhibitor 12 CDK2 Inhibitor 16 CDK4 Inhibitor 12 CDK5 Inhibitor 6 GSK-3beta Inhibitor 3 PHA-533533 is an inhibitor of CDK1, CDK2, CDK4, CDK5, and GSK3B, which inhibits phosphorylation of downstream targets and may promote cell cycle arrest and apoptosis in cancer cells (PMID: 15828833, PMID: 24004674).
PBA2 BCR-ABL Inhibitor 23 GSK-3beta Inhibitor 3 PBA2 is a dual BCR-ABL and GSK3-beta inhibitor that inhibits tumor cell growth (AACR, Cancer Res: April 2016; Volume 57, Abstract #3915).
Ro 31-8220 Ro-31-8220|Ro 318220 GSK-3beta Inhibitor 3 PKC Inhibitor (Pan) 9 Ro 31-8220 is a pan-protein kinase C (PKC) inhibitor, with additional activity against additional kinases including GSK3-beta, which may increase apoptosis and decrease growth of tumor cells (PMID: 8373348, PMID: 10998351, PMID: 18281471).
Molecular Profile Protein Effect Treatment Approaches